about
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt ...
Read More
0.52
0.01
(1.96%)
399.5K
XNAS Volume
XNAS 13 Jan, 2026 2:13 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
IO Biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..